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Malignant priapism secondary to penile
metastases is a rare condition. This term
was originally used by Peacock in 1938 to describe a condi-
tion of painful induration and erection of the penis due to
metastatic infiltration by a neoplasm. In the current literature
there are 512 case reports. The primary tumor sites are blad-
der, prostate and rectum. The treatment has only palliative
intent and consists of local tumor excision, penectomy, radio-
therapy and chemotherapy. We present one case of malignant
priapism originated from prostate cancer, and two from
urothelial carcinoma of the bladder. Different approaches in
diagnosis and therapy were performed. The entire three
patient reported a relief of the pain following the treatment,
with an improvement of their quality of life, even though it
was only temporary as a palliative. Malignant priapism  is a
rare medical emergency. Penile/pelvis magnetic resonance
imaging (MRI) scan and corporal biopsies are considered an
effective method of diagnosis of the primary organ site. 
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with Gleason score 9 (4+5). As a result of his prostatec-
tomy and radiation therapy he developed erectile dys-
function which was well responding to Alprostradil 20
micrograms. Two years postoperatively the patient was
admitted to A&E with 8-week history of persistent and
painful erection. On clinical examination the penis was
tender and some nodules and warts were noted along the
penile shaft and glans. The penile and pelvic MRI scan
showed that both corpora cavernosa had severe fibrosis
with thickening of the tunica and urethra throughout.
The glans appeared abnormal with a number of
exophitic lesions arising from it. Numerous bony metas-
tases were also seen within the inferior pubic ramus and
pubic symphysis and in the right acetabulum. A recur-
rent disease was noted at the level of the vescicourethral
anastomosis. A computed tomography (CT) total body
scan confirmed several small metastatic nodules within
the lungs. The bone scan showed osteoblastic metastases
in the lumbar spine and pelvis. In order to confirm the
diagnosis a glans wedge biopsy and multiple trucut biop-
sies of both corpora were performed. The final
histopathology report showed extensive infiltration by
metastatic prostatic adenocarcinoma composed mainly
of fused acinar structures (equivalent to Gleason 4 pat-
tern) with focal lymphovascular and perineural invasion.
After multidisciplinary team meeting discussion, he was
offered a penile palliative radiotherapy and a pudendal
nerve block to alleviate his pain and hormonal therapy. 
Case 2: a 48 year old patient underwent radical cysto-
prostatectomy with extended lymph node dissection and
formation of an ileal conduit for urothelial bladder carci-
noma (pT4a pN0). A month later the patient was read-
mitted with 7 days history of ischemic priapism, refrac-
tory to primary treatment and T shunt. During the T
shunt bilateral corporal biopsies were obtained and con-
firmed the presence of recurrence of primary disease.
Following the multi disciplinary team meeting outcome
the patient was offered a palliative penectomy followed
by adjuvant chemotherapy. A palliative radical penecto-
my with formation of perineal urethrostomy was per-
formed. The final histological report showed extensive
infiltration along the entire length of the penis, the fea-
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INTRODUCTION
Malignant priapism secondary to penile metastases is a
rare condition. This term was originally used by Peacock
in 1938 to describe a condition of painful induration
and erection of the penis due to infiltration by metastat-
ic neoplasm. Clinical manifestations of penile metastasis
are priapism, painful or painless palpable penile nod-
ules, swelling, haematuria and urinary retention. In the
current literature there are 512 case reports. The pri-
mary tumor sites are usually the bladder, prostate and
rectum. The treatment has only palliative intent and
consists of hormone therapy, chemotherapy, radiothera-
py, local tumor excision and penectomy.
PRESENTATION OF CASE(S)
We reported three cases of malignant priapism.
Case 1: a 62 year old man with diabetes mellitus type II
and a history of prostate cancer underwent laparoscopic
radical prostatectomy, followed by salvage radiotherapy.
The histopathology report showed advanced disease
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tures are consistent with high grade urothelial carcino-
ma, with focal sarcomatoid differentiation.
Case 3: A 72 year old man, with a history of urothelial
cell carcinoma of the bladder and concurrent incidental
primary rectal adenocarcinoma in April 2008, under-
went laparoscopic anterior resection and radical cystec-
tomy with formation of ileal conduit. The bowel histol-
ogy showed upper rectal G2pT1 N1 disease fully resect-
ed- with no vascular invasion and the bladder histology
showed G3pT4a (prostate) N2 disease with extensive
vascular invasion. Therefore the patient had adjuvant
chemotherapy. A CT scan and positron emission tomog-
raphy (PET) post chemotherapy underlined a new lesion
at right lower lobe of the lung. The biopsy of this lesion
showed metastatic urothelial cancer. One year postoper-
atively the patient was admitted with a 4 day history of
pain in his genitalia. The clinical examination revealed a
semi-erect firm glans, with palpable tumour nodules.
Abdomen MRI confirmed the presence of extensive
pelvic lymph nodes. The clinical progression of pri-
apism, with excruciating pain non responding to con-
ventional medical therapy and conservative treatment,
led to the medical decision for a palliative radical penec-
tomy without any previous corporal biopsies, as the
diagnosis of metastatic cancer was clear on the MRI scan.
DISCUSSION
To date there are 512 published cases of secondary penile
metastasis, as a result of the 118 founded in our Pubmed
review of 64 published case reports of secondary penile
metastasis in the last 10 years (from January 2004 to May
2014) searching for “penile metastasis”, “penile metastases”,
“malignant priapism”, “secondary malignancy penis”, plus
the 394 cases reviewed by Yu-Hsiang L. et al. In our review
157(30.6%) patients present metastasis of bladder origin,
152(29.6%) from prostate, 72(14%) recto-sigmoid,
34(6.6%) kidney, 20(3.9%) lower GI (excluding recto-
sigmoid), 15(2.9%) testis, 13(2.5%) lung, 11(2.1%)
upper GI tract, 6(1.1%) bone, 5(0.9%) lymphoma,
4(0.7%) leukemia, 4(0.7%) melanoma, 4(0.7%) upper
airways, 3(0.5%) hepatobiliary, 2(0.3%) ureter, 1(0.1%)
tongue, 1(0.1%) thyroid, 1(0.1%) seminal vesicle,
1(0.1%) glomangiosarcoma and 6(1.1%) from others ori-
gin. The most common clinical signs of penile metastases
are, priapism (40%), painful or painless penile nodules
(27.5%), swelling (15%) pain (7.5%), haematuria (5%)
and urinary retention (5%) (1). The most common ways
in which the primary cancer can spread to the penis are;
the retrograde venous route due to the vast communica-
tion between the pelvic organs and dorsal venous system
of the penis; via retrograde lymphatic flow and direct
invasion from the close organs with advanced cancer.
Direct arterial spread is another route, but less common.
In our specific case the ischaemic priapism was due to the
invasion of malignant cells into the cavernous sinuses
blocking the venous draining veins, without blocking the
arterial flow (2). According to Kendi et al., the MRI scan
plays an important role in the diagnosis and stadiation
(3). However the key point in order to confirm the diag-
nosis and the primary site of neoplasm is the biopsy of the
corpora. Penile metastasis is an advanced stage related to
a poor prognosis; the treatment is just palliative in order
to improve the quality of life and reveal the pain. It could
be hormone therapy, chemotherapy, radiotherapy or sur-
gery (shunt or penectomy). The shunt surgery has limit-
ed success, especially if the duration of the iscahemic pri-
apism is more than 48 hours. MDT(multidisciplinary
team meeting) discussion should always be made for the
treatment management in each case. The overall survival
is 12 months (range 6-18 months) from the time of the
diagnosis.
Primary site Number of cases %
Bladder 157 30.6
Prostate 152 29.6
Recto-sigmoid 72 14
Kidney 34 6.6
Lower GI tract (excluding recto-sigmoid) 20 3.9
Testis 15 2.9
Lung 13 2.5
Upper GI tract 11 2.1
Bone 6 1.1
Lymphoma 5 0.9
Leukemia 4 0.7
Melanoma 4 0.7
Upper airways 4 0.7
Hepatobiliary 3 0.5
Ureter 2 0.3
Thyroid 1 0.1
Tongue 1 0.1
Seminal vesicle 1 0.1
Glomangiosarcoma 1 0.1
Other 6 1.1
Total 512
Table 1. 
Primary site of penile metastases.
Figure 1. 
Corpora cavernosa infiltrated
by tumor.
Figure 2. 
Extensive permeation of the
vascular channels of the
corpus spongiosum and
corpus cavernosum by TCC of
the bladder.
Figure 3. 
Evidence of intravascular
tumour thrombi.
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CONCLUSION
Malignant priapism is a rare event. The most frequent
primary sites are bladder, prostate and recto-sigmoid.
Corporal biopsies are considered an effective method of
diagnosis of the primary organ site.
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